A 78-year-old female, with a history of pT1N0 moderately differentiated adenocarcinoma of the rectosigmoid colon treated with anterior resection in May 2006, presented with a progressive rise in serum carcinoembryonic antigen (CEA) levels since 2022. This evidence concerns the gene CEACAM5 and adenocarcinoma.